|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 38/46 | |
| A01N 65/00 | |||
| A01N 63/02 | |||
| A61P 31/00 | |||
| A61P 31/04 | |||
| A61L 2/16 |
| (11) | Number of the document | 3064217 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15200616.9 |
| Date of filing the European patent application | 2010-01-06 | |
| (97) | Date of publication of the European application | 2016-09-07 |
| (45) | Date of publication and mention of the grant of the patent | 2018-04-18 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 142714 P | 2009-01-06 | US | |
| 153274 P | 2009-02-17 | US | |
| 170915 P | 2009-04-20 | US |
| (72) |
Fallon, Joan M., US
Heil, Matthew, US
Fallon, James J., US
|
| (73) |
Galenagen, LLC,
411 Theodore Fremd Avenue, Suite 206, Rye, NY 10580,
US
|
| (54) | COMPOSITIONS COMPRISING PROTEASE, AMYLASE AND LIPASE FOR USE IN THE TREATMENT OF STAPHYLOCOCCUS AUREUS INFECTIONS |
| COMPOSITIONS COMPRISING PROTEASE, AMYLASE AND LIPASE FOR USE IN THE TREATMENT OF STAPHYLOCOCCUS AUREUS INFECTIONS |